1.
Cholesterol malabsorption caused by sitostanol ester feeding and neomycin in pravastatin-treated hypercholesterolaemic patients
by VANHANEN, H
European journal of clinical pharmacology, 1994, Vol.47 (2), p.169-176

2.
Effect of statins on C-reactive protein in patients with coronary artery disease
by Strandberg, Timo E
The Lancet (British edition), 1999, Vol.353 (9147), p.118-119

3.
Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia
by VANHANEN, H
European journal of clinical pharmacology, 1992, Vol.42 (2), p.127-130

4.
Effects of acipimox and cholestyramine on serum lipoproteins, non-cholesterol sterols and cholesterol absorption and elimination
by GYLLING, H
European journal of clinical pharmacology, 1989, Vol.37 (2), p.111-115

5.
Frequency of lipid-lowering therapy after a coronary event in Helsinki, Finland
by Strandberg, Timo E
The American journal of cardiology, 1999, Vol.84 (1), p.95-95

6.
Ambulatory Monitoring Uncorrected for Placebo Overestimates Long-term Antihypertensive Action
by Staessen, Jan A
Hypertension (Dallas, Tex. 1979), 1996-03, Vol.27 (3), p.414-420

7.
Comparison of effects on sleep of lovastatin and pravastatin in hypercholesterolemia
by Partinen, Markku
The American journal of cardiology, 1994, Vol.73 (12), p.876-880
